Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Nootropics & Cognitive Enhancement
1
Posts
1
Users
0
Reactions
166
Views
Topic starter
27/08/2022 3:18 am
Trying to separate three different claims about bacopa monnieri: that it is the right molecule, that it is the right dose, and that it does something useful.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
The evidence is usually a handful of small trials and the effect is modest.
Where does the human data stop and the extrapolation start?